Pfizer (PFE) EBIT (QoQ) (2009 - 2026)
Powered by 
Analysis
Pfizer (PFE) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -20.31% |
| Mar 29, 2026 | 24.12% |
| Dec 31, 2025 | -33.29% |
| Sep 28, 2025 | 27.95% |
| Jun 29, 2025 | 1.90% |
| Sep 29, 2024 | 504.92% |
| Jun 30, 2024 | -57.19% |
| Mar 31, 2024 | 138.41% |
| Jul 2, 2023 | -55.82% |
| Jul 3, 2022 | 23.14% |
| Oct 3, 2021 | 199.21% |
| Jul 4, 2021 | 21.20% |
| Sep 27, 2020 | 244.30% |
| Jun 28, 2020 | -24.12% |
| Mar 29, 2020 | 195.00% |
| Dec 31, 2019 | -197.84% |
| Sep 29, 2019 | -23.89% |
| Jun 30, 2019 | -2.11% |
| Mar 31, 2019 | 213.76% |
| Dec 31, 2018 | -198.07% |